SCHEMBL7195

SCHEMBL7195

Cc1noc(-c2ccc(Br)cc2)c1C(O)C[S@@+]([O-])Cc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LPAR1 Q92633 2/20 0.34
BRD2 P25440 3/20 0.33
BRD3 Q15059 2/20 0.33
STAT3 P40763 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP2D6 P10635 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194 1.00 BRD4 (0.34) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL7196 0.82 SMN1; SMN2 (0.34) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL6838 0.81 L3MBTL1 (0.40) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL13830791 0.80 LPAR1 (0.39) BRD4SMN1; SMN2LPAR1BRD2BRD3
SCHEMBL6830 0.79 RAB9A (0.34) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL2086 0.79 LPAR1 (0.38) SMN1; SMN2LMNARAB9AL3MBTL1LPAR1
SCHEMBL1924 0.79 AR (0.38) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL6942 0.79 LPAR1 (0.38) SMN1; SMN2LMNARAB9AL3MBTL1LPAR1
SCHEMBL1908 0.79 AR (0.38) BRD4SMN1; SMN2LMNARAB9AL3MBTL1
SCHEMBL6663 0.78 ABCC3 (0.42) LPAR1CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed